Biotechnology Assets S.A. (BST) — Cash Flow Quality Index
Biotechnology Assets S.A. (BST) has a Cash Flow Quality Index of -0.32x as of June 2023. Operating cash flow of €-935.60K is below net income of €2.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Biotechnology Assets S.A. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotechnology Assets S.A. Cash Flow Quality Index (2014–2023)
Historical Cash Flow Quality Index for Biotechnology Assets S.A. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Biotechnology Assets S.A. operating cash flow efficiency.
Annual Cash Flow Quality Index for Biotechnology Assets S.A. (2014–2023)
Year-by-year earnings quality comparison for Biotechnology Assets S.A..
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.02x | €47.74K | €2.32 Million | ▲ +105.1% |
| 2014 | -0.40x | €-303.79K | €756.27K | — |